BeOne Medicines (ONC) free cash flow

Free cash flow · fiscal 2025
$861.05M

BeOne Medicines (ONC) generated free cash flow of $861.05M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$669.77M. Figures as of 18 Nov 2026, 12:01 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$861.05M
Highest on record
$861.05Mfiscal 2025
Lowest on record
-$1.97Bfiscal 2022
Fiscal years on record
122014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

BeOne Medicines free cash flow, in more detail

Across the 12 fiscal years on record (2014–2025), the highest was $861.05M in fiscal 2025 and the lowest -$1.97B in fiscal 2022.

History · 12 fiscal years

Free cash flow by fiscal year

BeOne Medicines free cash flow, year by year

BeOne Medicines (ONC) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$861.05M—
2024-$669.77M—
2023-$1.75B—
2022-$1.97B—
2021-$1.56B—
2020-$1.40B—
2019-$839.88M—
2018-$618.00M—
2017-$33.62M—
2016-$113.02M—
2015-$45.16M—
2014-$9.35M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of BeOne Medicines and comparable companies
CompanyFree cash flowFiscal year
Agilent Technologies A$1.15B2025
Teva Pharmaceutical Industries TEVA$1.15B2025
BeOne Medicines ONC$861.05M2025
Waters WAT$539.81M2025
Natera NTRA$76.11M2025
IQVIA Holdings IQV$2.05B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ONC

BeOne Medicines, figure by figure

BeOne Medicines (ONC) overview: price, valuation and scorecardAll health care companies by market value

BeOne Medicines free cash flow: questions and answers

What is BeOne Medicines's free cash flow?

BeOne Medicines (ONC) generated free cash flow of $861.05M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$669.77M.

What are the highest and lowest free cash flow figures on record for BeOne Medicines?

Across the 12 fiscal years on record (2014–2025), the highest was $861.05M in fiscal 2025 and the lowest -$1.97B in fiscal 2022.

How is BeOne Medicines's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For BeOne Medicines it is on record here for 12 fiscal years, 2014 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “BeOne Medicines (ONC) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/ONC/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.